T 0323/19 (SGLT inhibitor tablet/JANSSEN) of 11.02.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T032319.20220211
- Date of decision
- 11 February 2022
- Case number
- T 0323/19
- Petition for review of
- -
- Application number
- 11721616.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL FORMULATIONS COMPRISING 1-(BETA-D-GLUCOPYRANOSYL)-2-THIENYLMETHYLBENZENE DERIVATIVES AS INHIBITORS OF SGLT
- Applicant name
- Janssen Pharmaceutica, N.V.
- Opponent name
- LEK Pharmaceutical
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2) (2007)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
The patent is revoked.